Larimar Therapeutics Ownership 2024 | Who Owns Larimar Therapeutics Now?
Institutional Ownership
113.11%
Insider Ownership
1.45%
Retail Ownership
-14.56%
Institutional Holders
101.00
Larimar Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 39.65% | 2.56% | 21,231,974 | - | - | 153,931,812 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 11.29% | 0.58% | 6,045,351 | - | - | 43,828,795 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 8.17% | 0.02% | 4,377,388 | 356,423 | 8.86% | 31,626,628 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 8.09% | 0.01% | 4,332,793 | 915,195 | 26.78% | 31,412,749 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 7.21% | 7.78% | 3,859,468 | -135,000 | -3.38% | 27,981,143 | Jun 30, 2024 |
| BLACKROCK INC. | 5.85% | 0.00% | 3,134,050 | 795,188 | 34.00% | 22,721,863 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.74% | 0.00% | 2,537,489 | 169,788 | 7.17% | 18,396,795 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 2.98% | 0.06% | 1,594,150 | 92,531 | 6.16% | 11,557,588 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.56% | 0.02% | 1,371,500 | -61,953 | -4.32% | 9,943,375 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.45% | 0.09% | 1,314,106 | 225,879 | 20.76% | 9,527,269 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.32% | 0.09% | 1,242,585 | 92,252 | 8.02% | 9,008,741 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 0.00% | 1,139,123 | 269,740 | 31.03% | 8,260,760 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.90% | 0.00% | 1,018,135 | 235,865 | 30.15% | 7,381,479 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 1.74% | 0.03% | 933,494 | -54,439 | -5.51% | 6,767,832 | Jun 30, 2024 |
| STATE STREET CORP | 1.71% | 0.00% | 916,201 | 285,521 | 45.27% | 6,642,457,000 | Jun 30, 2024 |
| MANGROVE PARTNERS | 1.60% | 0.48% | 855,815 | - | - | 6,204,659 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.53% | 0.03% | 821,687 | 271,660 | 49.39% | 5,957,231 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.32% | 1.50% | 704,349 | -36,528 | -4.93% | 5,106,530 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.29% | 2.05% | 693,000 | -2,000 | -0.29% | 5,024,250 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.20% | 1.11% | 639,974 | -16,399 | -2.50% | 4,639,812 | Jun 30, 2024 |
Larimar Therapeutics's largest institutional shareholder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), holding 39.65% of the company's total share outstanding, currently valued at $153.93M. The top 10 institutional shareholders own together 92.99% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLUE OWL CAPITAL HOLDINGS LP | 7.21% | 7.78% | 3,859,468 | -135,000 | -3.38% | 27,981,143 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 39.65% | 2.56% | 21,231,974 | - | - | 153,931,812 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.29% | 2.05% | 693,000 | -2,000 | -0.29% | 5,024,250 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.32% | 1.50% | 704,349 | -36,528 | -4.93% | 5,106,530 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.20% | 1.11% | 639,974 | -16,399 | -2.50% | 4,639,812 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.37% | 0.58% | 196,000 | 196,000 | 100.00% | 1,421,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 11.29% | 0.58% | 6,045,351 | - | - | 43,828,795 | Jun 30, 2024 |
| MANGROVE PARTNERS | 1.60% | 0.48% | 855,815 | - | - | 6,204,659 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.60% | 0.41% | 323,528 | -115,000 | -26.22% | 2,345,578 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.58% | 0.31% | 312,469 | 312,469 | 100.00% | 2,265,400 | Jun 30, 2024 |
| ATLAS VENTURE ADVISORS, INC. | 0.32% | 0.27% | 172,184 | -60,000 | -25.84% | 1,248,334 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.17% | 0.13% | 90,490 | 32,300 | 55.51% | 656,053 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.39% | 0.09% | 207,783 | 5,000 | 2.47% | 1,506,427 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.45% | 0.09% | 1,314,106 | 225,879 | 20.76% | 9,527,269 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.32% | 0.09% | 1,242,585 | 92,252 | 8.02% | 9,008,741 | Jun 30, 2024 |
| FI3 FINANCIAL ADVISORS, LLC | 0.04% | 0.07% | 20,387 | -5,061 | -19.89% | 147,806 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 2.98% | 0.06% | 1,594,150 | 92,531 | 6.16% | 11,557,588 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.53% | 0.03% | 821,687 | 271,660 | 49.39% | 5,957,231 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.03% | 9,342 | 9,342 | 100.00% | 67,730 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 1.74% | 0.03% | 933,494 | -54,439 | -5.51% | 6,767,832 | Jun 30, 2024 |
The largest Larimar Therapeutics shareholder by % of total assets is BLUE OWL CAPITAL HOLDINGS LP. The company owns 3.86M shares of Larimar Therapeutics (LRMR), representing 7.78% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 8.09% | 0.01% | 4,332,793 | 915,195 | 26.78% | 31,412,749 | Jun 30, 2024 |
| BLACKROCK INC. | 5.85% | 0.00% | 3,134,050 | 795,188 | 34.00% | 22,721,863 | Jun 30, 2024 |
| FMR LLC | 0.98% | 0.00% | 525,721 | 525,005 | 73324.72% | 3,811,477 | Jun 30, 2024 |
| INVESCO LTD. | 0.82% | 0.00% | 441,287 | 429,471 | 3634.66% | 3,199,331 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 8.17% | 0.02% | 4,377,388 | 356,423 | 8.86% | 31,626,628 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.58% | 0.31% | 312,469 | 312,469 | 100.00% | 2,265,400 | Jun 30, 2024 |
| STATE STREET CORP | 1.71% | 0.00% | 916,201 | 285,521 | 45.27% | 6,642,457,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.53% | 0.03% | 821,687 | 271,660 | 49.39% | 5,957,231 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 0.00% | 1,139,123 | 269,740 | 31.03% | 8,260,760 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.90% | 0.00% | 1,018,135 | 235,865 | 30.15% | 7,381,479 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.45% | 0.09% | 1,314,106 | 225,879 | 20.76% | 9,527,269 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.37% | 0.58% | 196,000 | 196,000 | 100.00% | 1,421,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.74% | 0.00% | 2,537,489 | 169,788 | 7.17% | 18,396,795 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.13% | 0.01% | 603,581 | 165,181 | 37.68% | 4,375,963 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.35% | 0.02% | 186,174 | 139,980 | 303.03% | 1,349,762 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.39% | 0.00% | 210,828 | 104,598 | 98.46% | 1,528,503 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 2.98% | 0.06% | 1,594,150 | 92,531 | 6.16% | 11,557,588 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.32% | 0.09% | 1,242,585 | 92,252 | 8.02% | 9,008,741 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.25% | 0.00% | 134,877 | 49,102 | 57.25% | 977,860 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.24% | 0.00% | 128,095 | 45,086 | 54.31% | 928,689 | Jun 30, 2024 |
As of Jun 30 2024, Larimar Therapeutics's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased 915.20K stocks of LRMR, valued at $31.41M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| RTW INVESTMENTS, LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -266,400 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.52% | 0.00% | 278,342 | -225,100 | -44.71% | 2,017,980 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -210,603 | -100.00% | - | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -174,413 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -148,100 | -100.00% | - | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 7.21% | 7.78% | 3,859,468 | -135,000 | -3.38% | 27,981,143 | Jun 30, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | - | - | - | -123,325 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.60% | 0.41% | 323,528 | -115,000 | -26.22% | 2,345,578 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 18,346 | -100,541 | -84.57% | 133,009 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -89,094 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -84,500 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -80,900 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.56% | 0.02% | 1,371,500 | -61,953 | -4.32% | 9,943,375 | Jun 30, 2024 |
| ATLAS VENTURE ADVISORS, INC. | 0.32% | 0.27% | 172,184 | -60,000 | -25.84% | 1,248,334 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.28% | 0.00% | 150,657 | -59,815 | -28.42% | 1,092,263 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 1.74% | 0.03% | 933,494 | -54,439 | -5.51% | 6,767,832 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | - | - | - | -48,272 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Larimar Therapeutics's biggest institutional seller is LOGOS GLOBAL MANAGEMENT LP. The company sold -0.70M shares of LRMR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 0.58% | 0.31% | 312,469 | 312,469 | 100.00% | 2,265,400 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.37% | 0.58% | 196,000 | 196,000 | 100.00% | 1,421,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.08% | 0.00% | 41,683 | 41,683 | 100.00% | 302,202 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | 0.00% | 29,858 | 29,858 | 100.00% | 216,471 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.05% | 0.00% | 27,790 | 27,790 | 100.00% | 201,478 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 22,632 | 22,632 | 100.00% | 164,082 | Jun 30, 2024 |
| BALLENTINE PARTNERS, LLC | 0.04% | 0.00% | 18,852 | 18,852 | 100.00% | 136,677 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.03% | 0.00% | 16,615 | 16,615 | 100.00% | 120,459 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.03% | 0.01% | 16,580 | 16,580 | 100.00% | 120,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.03% | - | 16,174 | 16,174 | 100.00% | 117,262 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.03% | 0.00% | 15,626 | 15,626 | 100.00% | 113,289 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.02% | 15,090 | 15,090 | 100.00% | 109,403 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.03% | - | 13,460 | 13,460 | 100.00% | 98,000 | Jun 30, 2024 |
| THOROUGHBRED FINANCIAL SERVICES, LLC | 0.02% | 0.01% | 13,100 | 13,100 | 100.00% | 94,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 13,016 | 13,016 | 100.00% | 94,366 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.03% | 9,342 | 9,342 | 100.00% | 67,730 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,755 | 1,755 | 100.00% | 12,723 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 10,875 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,126 | 1,126 | 100.00% | 8,164 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 286 | 286 | 100.00% | 2,074 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | 0.00% | 125 | 125 | 100.00% | 906 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 85 | 85 | 100.00% | 616 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 15 | 15 | 100.00% | 109 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | 1 | 1 | 100.00% | 7,000 | Jun 30, 2024 |
Larimar Therapeutics's largest new institutional shareholder by number of shares is SPHERA FUNDS MANAGEMENT LTD., purchased 312.47K shares, valued at $2.27M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| RTW INVESTMENTS, LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -266,400 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -210,603 | -100.00% | - | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -174,413 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -148,100 | -100.00% | - | Jun 30, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | - | - | - | -123,325 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -89,094 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -84,500 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -80,900 | -100.00% | - | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | - | - | - | -48,272 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -21,142 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -18,600 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -17,578 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -16,906 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -13,927 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,825 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -8,638 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,410 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -415 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -75 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Larimar Therapeutics's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.70M shares, valued at -, as of undefined.
Larimar Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER FUNDS II | 0.80% | 181,207 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.18% | 175,870 | - | - | Jan 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.06% | 28,064 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.04% | 3,570 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 18,649 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 81,700 | -35,000 | -29.99% | Mar 28, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 88,727 | 88,727 | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 49,990 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,960 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,165,221 | 414,720 | 23.69% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 400,992 | 71,346 | 21.64% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 73,763 | - | - | Jan 31, 2024 |
| GABELLI EQUITY TRUST INC | 0.00% | 1,833 | - | - | Dec 29, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,118 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,109 | -2,069 | -7.90% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 45,772 | 45,772 | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 49,676 | 49,676 | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 969 | -1,868 | -65.84% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,682 | -2,791 | -24.33% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,314 | 420 | 46.98% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 4,749 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,100 | 1,200 | 15.19% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 13,064 | 1,548 | 13.44% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 113,583 | 1,853 | 1.66% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 12,756 | 8,629 | 209.09% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,107 | -1,075 | -8.16% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,731 | 465 | 36.73% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 79,221 | 79,221 | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,011,180 | 53,671 | 5.61% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 234 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 111,663 | 12,679 | 12.81% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 19,477 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 13,163 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 47,784 | -80 | -0.17% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 9,842 | -40 | -0.40% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,299 | 661 | 18.17% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 116 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 2,633 | 1,000 | 61.24% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | -500 | -45.45% | Mar 28, 2024 |
| ETF Series Solutions | 0.00% | 405 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 202 | -13 | -6.05% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,727 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,759 | 449 | 13.56% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,391 | -1,221 | -26.47% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 15 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 35,655 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 8,858 | 8,858 | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 23,854 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,906 | -11 | -0.38% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 19,396 | -537 | -2.69% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 9,179 | 4,133 | 81.91% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 11,149 | 1,590 | 16.63% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 10,761 | 1,328 | 14.08% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 333 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 75 | 75 | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,087 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,234 | -340 | -9.51% | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 4,450 | 4,450 | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 845 | -3,328 | -79.75% | Jan 31, 2024 |
Larimar Therapeutics's largest mutual fund holder by % of total assets is "ALGER FUNDS II", owning 181.21K shares, compromising 0.80% of its total assets.
Larimar Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 101 | -9.82% |
| 31 Mar, 24 | 112 | 51.35% |
| 31 Dec, 23 | 74 | 10.45% |
| 30 Sep, 23 | 67 | - |
| 30 Jun, 23 | 67 | -2.90% |
| 31 Mar, 23 | 69 | 43.75% |
| 31 Dec, 22 | 48 | -9.43% |
| 30 Sep, 22 | 53 | 47.22% |
| 30 Jun, 22 | 36 | -16.28% |
| 31 Mar, 22 | 43 | -8.51% |
| 31 Dec, 21 | 47 | -7.84% |
| 30 Sep, 21 | 51 | 15.91% |
| 30 Jun, 21 | 44 | -18.52% |
| 31 Mar, 21 | 54 | 28.57% |
| 31 Dec, 20 | 42 | 13.51% |
| 30 Sep, 20 | 37 | 5.71% |
| 30 Jun, 20 | 35 | - |
As of 30 Jun 24, 101 institutions are holding Larimar Therapeutics's shares, representing a decrease of -9.82% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 60,572,859 | -4.75% |
| 31 Mar, 24 | 63,594,673 | 61.18% |
| 31 Dec, 23 | 39,456,509 | 1.83% |
| 30 Sep, 23 | 38,745,794 | -0.72% |
| 30 Jun, 23 | 39,027,692 | 1.47% |
| 31 Mar, 23 | 38,462,509 | -0.83% |
| 31 Dec, 22 | 38,784,114 | 1.60% |
| 30 Sep, 22 | 38,172,308 | 165.22% |
| 30 Jun, 22 | 14,392,563 | -5.67% |
| 31 Mar, 22 | 15,257,581 | 4.74% |
| 31 Dec, 21 | 14,567,349 | 0.98% |
| 30 Sep, 21 | 14,425,480 | -0.82% |
| 30 Jun, 21 | 14,544,123 | 3.07% |
| 31 Mar, 21 | 14,110,497 | -1.00% |
| 31 Dec, 20 | 14,252,355 | 4.60% |
| 30 Sep, 20 | 13,625,016 | 5.19% |
| 30 Jun, 20 | 12,953,240 | - |
Larimar Therapeutics (LRMR) has 60.57M shares outstanding as of 30 Jun 24, down -4.75% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.11% | 0.54% |
| 31 Mar, 24 | 144.84% | 1.79% |
| 31 Dec, 23 | 89.87% | 1.15% |
| 30 Sep, 23 | 88.26% | 1.12% |
| 30 Jun, 23 | 88.91% | 1.16% |
| 31 Mar, 23 | 87.62% | 0.39% |
| 31 Dec, 22 | 150.55% | 0.51% |
| 30 Sep, 22 | 171.73% | 2.79% |
| 30 Jun, 22 | 78.48% | 1.13% |
| 31 Mar, 22 | 83.20% | 1.32% |
| 31 Dec, 21 | 79.43% | 1.28% |
| 30 Sep, 21 | 78.88% | 0.95% |
| 30 Jun, 21 | 90.92% | 1.17% |
| 31 Mar, 21 | 88.21% | 0.61% |
| 31 Dec, 20 | 119.94% | 1.65% |
| 30 Sep, 20 | 85.24% | 0.45% |
| 30 Jun, 20 | 138.07% | - |
As of 30 Jun 24, Larimar Therapeutics is held by 113.11% institutional shareholders, representing a 0.54% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 59 | -21.33% |
| 31 Mar, 24 | 75 | 150.00% |
| 31 Dec, 23 | 30 | 15.38% |
| 30 Sep, 23 | 26 | -33.33% |
| 30 Jun, 23 | 39 | -17.02% |
| 31 Mar, 23 | 47 | 74.07% |
| 31 Dec, 22 | 27 | -25.00% |
| 30 Sep, 22 | 36 | 1100.00% |
| 30 Jun, 22 | 3 | -81.25% |
| 31 Mar, 22 | 16 | - |
| 31 Dec, 21 | 16 | -42.86% |
| 30 Sep, 21 | 28 | 12.00% |
| 30 Jun, 21 | 25 | -3.85% |
| 31 Mar, 21 | 26 | 23.81% |
| 31 Dec, 20 | 21 | 23.53% |
| 30 Sep, 20 | 17 | -51.43% |
| 30 Jun, 20 | 35 | - |
59 institutional shareholders have increased their position in LRMR stock as of 30 Jun 24 compared to 75 in the previous quarter (a -21.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 31 | 40.91% |
| 31 Mar, 24 | 22 | -15.38% |
| 31 Dec, 23 | 26 | 8.33% |
| 30 Sep, 23 | 24 | 84.62% |
| 30 Jun, 23 | 13 | 8.33% |
| 31 Mar, 23 | 12 | 33.33% |
| 31 Dec, 22 | 9 | 50.00% |
| 30 Sep, 22 | 6 | -57.14% |
| 30 Jun, 22 | 14 | 40.00% |
| 31 Mar, 22 | 10 | -23.08% |
| 31 Dec, 21 | 13 | 44.44% |
| 30 Sep, 21 | 9 | 12.50% |
| 30 Jun, 21 | 8 | -42.86% |
| 31 Mar, 21 | 14 | 75.00% |
| 31 Dec, 20 | 8 | 33.33% |
| 30 Sep, 20 | 6 | - |
| 30 Jun, 20 | - | - |
31 institutional shareholders have reduced their position in LRMR stock as of 30 Jun 24 compared to 22 in the previous quarter (a 40.91% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 101 | -9.82% | 60,572,859 | -4.75% | 113.11% | 0.54% | 59 | -21.33% | 31 | 40.91% |
| 31 Mar, 24 | 112 | 51.35% | 63,594,673 | 61.18% | 144.84% | 1.79% | 75 | 150.00% | 22 | -15.38% |
| 31 Dec, 23 | 74 | 10.45% | 39,456,509 | 1.83% | 89.87% | 1.15% | 30 | 15.38% | 26 | 8.33% |
| 30 Sep, 23 | 67 | - | 38,745,794 | -0.72% | 88.26% | 1.12% | 26 | -33.33% | 24 | 84.62% |
| 30 Jun, 23 | 67 | -2.90% | 39,027,692 | 1.47% | 88.91% | 1.16% | 39 | -17.02% | 13 | 8.33% |
| 31 Mar, 23 | 69 | 43.75% | 38,462,509 | -0.83% | 87.62% | 0.39% | 47 | 74.07% | 12 | 33.33% |
| 31 Dec, 22 | 48 | -9.43% | 38,784,114 | 1.60% | 150.55% | 0.51% | 27 | -25.00% | 9 | 50.00% |
| 30 Sep, 22 | 53 | 47.22% | 38,172,308 | 165.22% | 171.73% | 2.79% | 36 | 1100.00% | 6 | -57.14% |
| 30 Jun, 22 | 36 | -16.28% | 14,392,563 | -5.67% | 78.48% | 1.13% | 3 | -81.25% | 14 | 40.00% |
| 31 Mar, 22 | 43 | -8.51% | 15,257,581 | 4.74% | 83.20% | 1.32% | 16 | - | 10 | -23.08% |
| 31 Dec, 21 | 47 | -7.84% | 14,567,349 | 0.98% | 79.43% | 1.28% | 16 | -42.86% | 13 | 44.44% |
| 30 Sep, 21 | 51 | 15.91% | 14,425,480 | -0.82% | 78.88% | 0.95% | 28 | 12.00% | 9 | 12.50% |
| 30 Jun, 21 | 44 | -18.52% | 14,544,123 | 3.07% | 90.92% | 1.17% | 25 | -3.85% | 8 | -42.86% |
| 31 Mar, 21 | 54 | 28.57% | 14,110,497 | -1.00% | 88.21% | 0.61% | 26 | 23.81% | 14 | 75.00% |
| 31 Dec, 20 | 42 | 13.51% | 14,252,355 | 4.60% | 119.94% | 1.65% | 21 | 23.53% | 8 | 33.33% |
| 30 Sep, 20 | 37 | 5.71% | 13,625,016 | 5.19% | 85.24% | 0.45% | 17 | -51.43% | 6 | - |
| 30 Jun, 20 | 35 | - | 12,953,240 | - | 138.07% | - | 35 | - | - | - |
Larimar Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of LRMR was made by Hamilton Thomas Edward on May 31 2024, buying 57,208 shares at $8.74 per share (worth $500.00K).
Larimar Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | - | - |
| Q1 2024 | 13 | - | - |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 5 | - | - |
| Q3 2022 | 7 | 1 | 700.00% |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 2 | - | - |
| Q2 2021 | 11 | - | - |
| Q1 2021 | 2 | - | - |
| Q3 2020 | 9 | - | - |
| Q2 2020 | 4 | 3 | 133.33% |
| Q2 2019 | 8 | - | - |
| Q1 2019 | 10 | - | - |
| Q2 2018 | 9 | 3 | 300.00% |
| Q1 2018 | 10 | 1 | 1000.00% |
| Q4 2017 | 4 | - | - |
| Q3 2017 | 1 | - | - |
| Q2 2017 | 13 | 3 | 433.33% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Larimar Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | 5 | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 3 | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 7 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | 4 | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q2 2018 | - | 1 | - |
| Q1 2018 | - | 1 | - |
| Q4 2017 | 1 | - | - |
| Q3 2017 | 1 | - | - |
| Q2 2017 | 2 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Larimar Therapeutics's stocks.
Larimar Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| IKNA | Ikena Oncology, Inc. |
| MRUS | Merus N.V. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ALEC | Alector, Inc. |
| STRO | Sutro Biopharma, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| SRZN | Surrozen, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| CABA | Cabaletta Bio, Inc. |
| KROS | Keros Therapeutics, Inc. |
| PCVX | Vaxcyte, Inc. |
| IMRX | Immuneering Corporation |
| NLTX | Neurogene Inc. |
| KZR | Kezar Life Sciences, Inc. |
| CHRS | Coherus BioSciences, Inc. |
| FIXX | Q32 Bio Inc. |
| CELC | Celcuity Inc. |
LRMR Ownership FAQ
Who Owns Larimar Therapeutics?
Larimar Therapeutics is owned by institutional shareholders (113.11%), insiders (1.45%), and public (-14.56%). The largest institutional shareholder of Larimar Therapeutics is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (39.65% of total shares) and the top mutual fund owner is ALGER FUNDS II (0.80% of total shares).
Who are the major institutional shareholders of Larimar Therapeutics?
Larimar Therapeutics's major institutional shareholders are DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, GOLDMAN SACHS GROUP INC, and BLUE OWL CAPITAL HOLDINGS LP. The top five shareholders own together 74.41% of the company's share outstanding.
How many Larimar Therapeutics shareholders are there?
As of Jun 2024, there are 101 institutional shareholders of Larimar Therapeutics.
What percentage of Larimar Therapeutics is owned by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)?
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) owns 21.23M shares of Larimar Therapeutics, representing 39.65% of the company's total shares outstanding, valued at $153.93M (as of Jun 2024).
What percentage of Larimar Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 6.05M shares of Larimar Therapeutics (LRMR), compromising 11.29% of the company, valued at $43.83M.
What percentage of Larimar Therapeutics is owned by JANUS HENDERSON GROUP PLC?
JANUS HENDERSON GROUP PLC is the third largest holder of Larimar Therapeutics. The company owns 4.38M of the company's shares outstanding (worth $31.63M).